What do we do?
MANUFACTURING & Services
Development and manufacturing (in GMP , ISO 13485, HACCP, ISO 22000) of finished products in solid & liquid dosage oral forms
S.I.I.T. develops technologies for improving performances of customer product
A complete pipeline of innovative consumer healthcare product ready to license out.
Who are we?
Innovative Healthcare Products
S.I.I.T. is a privately owned company founded in 1951, as a pharmaceutical contract packaging company, in the 2nd half of the 80’s it started an important transformation, 3 important steps in the evolution process: contract manufacturing of health food supplements (1985), extension to pharmaceutical contract manufacturing (1994), research & development health food supplement division (2001) to offer its customers a global service, contract development and production. The company is organized in 2 competence units: Production of solid oral dosage forms (powder in sachets, tablets, capsules in blisters and bottles for pharmaceutical and health food supplements) offers a dedicated specialized production unit according to International Regulation statement for each type of production (Pharmaceutical/Health Food supplements), a complete respect of GMP (Pharmaceuticals) and HACCP (Health Food Supplements), high quality control services (chemical-physicals and microbiological) performed in our laboratories from qualified staff and modern instruments. The turnover growth rate of the last 10 years was 15% per year. Research & Development (R&D) offers a highly professional team dedicated to development of innovative health food supplements. The R&D department employs 10% of the total staff and the corresponds to the 4% of the global turnover.
Market share of Italian Health food supplements contract manufacturing
Market share of West Europe HSF contract manufacturing
million units produced in 2015
Events & Links
MARCH 2017, EP3023093 (A1) MEDICINAL PREPARATION BASED ON DIOSMECTITE Intention to grant Disclosed is an oral composition for the treatment of diarrhoea, containing diosmectite in aqueous suspension, karaya gum and optionally, pharmaceutically acceptable excipients. JUNE 2017, European Patent ORAL COMPOSITIONS FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE Publication of the Text with search report Nr.[…]
Federsalus ha un nuovo presidente. Andrea Costa è stato eletto all’unanimità alla guida dell’associazione più rappresentativa del settore degli integratori alimentari. Obiettivi del mandato Il CEO di S.I.I.T. continuerà il percorso già avviato dall’Associazione e dalle precedenti presidenze, volto a migliorare il livello di qualità dell’intera filiera degli integratori alimentari, attraverso l’implementazione delle Buone Pratiche[…]